Copyright
©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Aug 7, 2006; 12(29): 4716-4720
Published online Aug 7, 2006. doi: 10.3748/wjg.v12.i29.4716
Published online Aug 7, 2006. doi: 10.3748/wjg.v12.i29.4716
N/OFQ | α-FP | |||
Sensitivity % (CI) | 21.4 | (0.06 - 0.36) | 46.4 | (0.29 - 0.64) |
Specificity % (CI) | 76.7 | (0.61 - 0.91) | 100 | (0.88 - 1.00) |
Positive predictive value % (CI) | 46.2 | (0.19 - 0.73) | 100 | (0.77 - 1.00) |
Negative predictive value % (CI) | 51.1 | (0.36 - 0.65) | 66.7 | (0.52 - 0.78) |
Positive likelihood ratio (CI) | 0.92 | (0.35 - 2.40) | ∞ | (4.01 - ∞) |
Negative likelihood ratio (CI) | 1.02 | (0.77 - 1.35) | 0.53 | (0.33 - ∞) |
- Citation: Spadaro A, Ajello A, Luigiano C, Morace C, Resta ML, Berlinghieri G, Campo S, Scisca C, Alibrandi A, D’arrigo G, Alessi N, Ferraù O, Freni MA. Low utility of plasma Nociceptin/orphanin FQ in the diagnosis of hepatocellular carcinoma. World J Gastroenterol 2006; 12(29): 4716-4720
- URL: https://www.wjgnet.com/1007-9327/full/v12/i29/4716.htm
- DOI: https://dx.doi.org/10.3748/wjg.v12.i29.4716